1.75
price up icon2.94%   0.05
after-market 시간 외 거래: 1.71 -0.04 -2.29%
loading
전일 마감가:
$1.70
열려 있는:
$1.7
하루 거래량:
309.99K
Relative Volume:
0.72
시가총액:
$240.78M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-4.7297
EPS:
-0.37
순현금흐름:
$-42.28M
1주 성능:
+2.94%
1개월 성능:
-9.33%
6개월 성능:
+2.94%
1년 성능:
-5.91%
1일 변동 폭
Value
$1.68
$1.795
1주일 범위
Value
$1.58
$1.83
52주 변동 폭
Value
$0.765
$2.34

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
명칭
Compass Therapeutics Inc
Name
전화
617-500-8099
Name
주소
80 GUEST STREET, BOSTON
Name
직원
32
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CMPX's Discussions on Twitter

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-01-31 개시 Jefferies Buy
2023-01-27 개시 Stifel Buy
2022-05-23 재개 H.C. Wainwright Buy
2022-03-15 개시 Ladenburg Thalmann Buy
2022-01-19 개시 B. Riley Securities Buy
2021-12-22 개시 Raymond James Outperform
2021-12-20 개시 SVB Leerink Outperform
2021-12-15 개시 Wedbush Outperform
모두보기

Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스

pulisher
Nov 04, 2024

Treatment Resistant Depression Pipeline Therapeutics, - openPR

Nov 04, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 31, 2024

Compass delays anticipated psilocybin readout, cuts staff - Yahoo Finance

Oct 31, 2024
pulisher
Oct 27, 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024 - MD Magazine

Oct 27, 2024
pulisher
Oct 17, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Treatment Resistant Depression Clinical Trials 2024: FDA - openPR

Oct 16, 2024
pulisher
Oct 15, 2024

Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 15, 2024
pulisher
Oct 15, 2024

Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Financial Snapshot: Analyzing Compass Therapeutics Inc (CMPX)’s Key Ratio Metrics - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

CMPX’s 2023 Market Dance: Up 26.92% – Time to Invest? - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Decreases Position in Imperial Petroleum Inc. (NASDAQ:IMPP) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

JetBlue Airways (NASDAQ:JBLU) Raised to “Sell” at StockNews.com - Defense World

Oct 14, 2024
pulisher
Oct 08, 2024

Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR

Oct 08, 2024
pulisher
Oct 08, 2024

Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Oct 08, 2024
pulisher
Oct 04, 2024

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com

Oct 04, 2024
pulisher
Oct 04, 2024

Compass Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire

Oct 04, 2024
pulisher
Oct 03, 2024

Compass Therapeutics Inc (CMPX)’s stock price range in the last year - US Post News

Oct 03, 2024
pulisher
Oct 02, 2024

American Century Companies Inc. Cuts Stake in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Oct 02, 2024
pulisher
Sep 30, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Rhumbline Advisers Takes Position in LINKBANCORP, Inc. (NASDAQ:LNKB) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World

Sep 30, 2024
pulisher
Sep 29, 2024

Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World

Sep 29, 2024
pulisher
Sep 27, 2024

NSK (OTCMKTS:NPSKY) Stock Price Passes Above 50-Day Moving Average of $10.02 - Defense World

Sep 27, 2024
pulisher
Sep 26, 2024

PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Gencor Industries, Inc. (NASDAQ:GENC) Shares Acquired by Renaissance Technologies LLC - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

First Trust Cloud Computing ETF (NASDAQ:SKYY) Sets New 52-Week High at $103.17 - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR

Sep 25, 2024
pulisher
Sep 25, 2024

Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 23, 2024

Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

Invesco Plc (IVZ-N) QuotePress Release - The Globe and Mail

Sep 20, 2024
pulisher
Sep 19, 2024

Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News

Sep 18, 2024
pulisher
Sep 17, 2024

Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN

Sep 17, 2024
pulisher
Sep 17, 2024

Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada

Sep 16, 2024
pulisher
Sep 16, 2024

Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat

Sep 16, 2024
pulisher
Sep 13, 2024

Executive team - Compass Pathways

Sep 13, 2024
pulisher
Sep 08, 2024

National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World

Sep 08, 2024
pulisher
Sep 06, 2024

Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex

Sep 06, 2024
pulisher
Sep 05, 2024

Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World

Sep 05, 2024

Compass Therapeutics Inc (CMPX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):